Success Metrics

Clinical Success Rate
87.1%

Based on 101 completed trials

Completion Rate
87%(101/116)
Active Trials
39(22%)
Results Posted
5%(5 trials)
Terminated
15(8%)

Phase Distribution

Ph not_applicable
32
18%
Ph early_phase_1
1
1%
Ph phase_2
7
4%
Ph phase_3
5
3%
Ph phase_1
2
1%

Phase Distribution

3

Early Stage

7

Mid Stage

5

Late Stage

Phase Distribution47 total trials
Early Phase 1First-in-human
1(2.1%)
Phase 1Safety & dosage
2(4.3%)
Phase 2Efficacy & side effects
7(14.9%)
Phase 3Large-scale testing
5(10.6%)
N/ANon-phased studies
32(68.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.2%

101 of 126 finished

Non-Completion Rate

19.8%

25 ended early

Currently Active

39

trials recruiting

Total Trials

180

all time

Status Distribution
Active(42)
Completed(101)
Terminated(25)
Other(12)

Detailed Status

Completed101
Recruiting29
Terminated15
unknown12
Active, not recruiting10
Withdrawn10

Development Timeline

Analytics

Development Status

Total Trials
180
Active
39
Success Rate
87.1%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (2.1%)
Phase 12 (4.3%)
Phase 27 (14.9%)
Phase 35 (10.6%)
N/A32 (68.1%)

Trials by Status

completed10156%
enrolling_by_invitation11%
not_yet_recruiting21%
unknown127%
terminated158%
active_not_recruiting106%
recruiting2916%
withdrawn106%

Recent Activity

Clinical Trials (180)

Showing 20 of 180 trialsScroll for more
NCT04000061

Heart Failure-USB: Prediction and Progression

Recruiting
NCT04242095

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Recruiting
NCT00769223

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Active Not Recruiting
NCT04984551Phase 2

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Recruiting
NCT04723095

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Recruiting
NCT06279013Not Applicable

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Recruiting
NCT06895681

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

Withdrawn
NCT02402244

Project: Every Child for Younger Patients With Cancer

Recruiting
NCT07659652

Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

Not Yet Recruiting
NCT01772771

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Recruiting
NCT00992303

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Recruiting
NCT06976502

Health eHeart BioBank

Enrolling By Invitation
NCT04431479

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Active Not Recruiting
NCT04656873

Immuno-Oncology Database and Bioregistry

Completed
NCT05677802Not Applicable

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Recruiting
NCT03199651Not Applicable

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Recruiting
NCT07602374Not Applicable

Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction

Recruiting
NCT05530759

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Recruiting
NCT04832763Not Applicable

Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer

Active Not Recruiting
NCT03737695

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
180